Substance / Medication

Tricyclic antidepressant

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

No related conditions have been mapped yet. Condition-intervention linkages are derived from SNOMED CT relationships and will expand as the knowledge graph grows.

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Association between tricyclic antidepressants and health outcomes among older people: A systematic review and meta-analysis.
Santandreu Javier, Caballero Francisco Félix, Gómez-Serranillos M Pilar et al. · Maturitas · 2024
PMID: 39089048Meta-Analysis
Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis.
Kamp Caroline Barkholt, Petersen Johanne Juul, Faltermeier Pascal et al. · BMJ Ment Health · 2024
PMID: 39093721Meta-AnalysisFull text (PMC)
The effect of smoking on the plasma concentration of tricyclic antidepressants: a systematic review.
Lundstrøm Nicklas Hasselblad, Holgersen Nikolaj K, Haastrup Maija Bruun · Acta Neuropsychiatr · 2022
PMID: 34497000Meta-Analysis
Dose effects of tricyclic antidepressants in the treatment of acute depression - A systematic review and meta-analysis of randomized trials.
Baethge Christopher, Braun Cora, Rink Lena et al. · J Affect Disord · 2022
PMID: 35390353Meta-Analysis
Biomarkers as predictors of treatment response to tricyclic antidepressants in major depressive disorder: A systematic review.
Ter Hark Sophie E, Vos Cornelis F, Aarnoutse Rob E et al. · J Psychiatr Res · 2022
PMID: 35397333Meta-Analysis
Treatment of insomnia with tricyclic antidepressants: a meta-analysis of polysomnographic randomized controlled trials.
Liu Yang, Xu Xiaomin, Dong Meixue et al. · Sleep Med · 2017
PMID: 28522080Meta-Analysis
Tricyclic antidepressants for preventing migraine in adults.
Xu Xiao-Min, Liu Yang, Dong Mei-Xue et al. · Medicine (Baltimore) · 2017
PMID: 28562550Meta-AnalysisFull text (PMC)
Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Otasowie John, Castells Xavier, Ehimare Umonoibalo P et al. · Cochrane Database Syst Rev · 2014
PMID: 25238582Meta-AnalysisFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Tricyclic antidepressant (substance)
SNOMED CT
373253007
UMLS CUI
C0003290

Clinical Data

This intervention maps to 0 entities in the Ltrl knowledge graph.

0
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.